DERMATOLOGICALS IN NORWAY

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Dermatologicals Sees Strong Growth

Antipruritics Is Set To See the Strongest Growth

Several Categories Are Set To Decline in the Forecast Period

Competitive Landscape

Aco Hud Norge Leads Dermatologicals

Bayer Is the Second Largest Company

Well-recognised Brands Benefit From Consumer Scepticism of Lesser-known Brands

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Modest Growth Due To Maturity

Demographic Trends and the Weather Affect Sales of Consumer Health Products

Norwegians Are Reluctant To Try New Brands in OTC Categories

Store-based Retailing Remains the Main Channel; Albeit Internet Retailing Is Growing

Most Trends Are Projected To Continue Throughout the Forecast Period

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Sources

Summary 2 Research Sources

Several categories within dermatologicals, such as antipruritics, are expected to show strong growth in the forecast period, whilst haemorrhoid treatments and topical allergy remedies/antihistamines are projected to show modest growth. Antipruritics is expected to see strong growth due to the need for eczema treatment and treatment for other skin problems. Haemorrhoid treatments is set to grow due to the increasing population aged 65+, as these people are, together with pregnant women, more like...

Euromonitor International's Dermatologicals in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.